Gyomor- és nyelőcsőrák: vizsgálatok itt: Kína
723 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleExploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis
- Where
- Hangzhou
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06881511 - 2. fázisNot yet taking people in KínaFruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 55
- Run by
- Ruijin Hospital
See details and how to joinNCT06888037 - No phaseNot yet taking people in KínaPrognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 600
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06889402 - 1/2. fázisNot yet taking people in KínaFruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 44
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06871527 - 2/3. fázisNot yet taking people in KínaTotal Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 474
- Run by
- YIN LI
See details and how to joinNCT06861777 - No phaseTaking peopleEnergy CT in Imaging and Diagnosis of Gastric Cancer
- Where
- Zhengzhou
- Életkor
- 18 év and over
- People
- 300
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06869694 - 1. fázisTaking peopleBC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 80
- Run by
- Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
See details and how to joinNCT06773312 - No phaseCsak meghívásosA Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 536
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06863831 - 1. fázisNot yet taking people in KínaPostoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients
- Where
- Beijing, Nanjing
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Peking University
See details and how to joinNCT06857786 - 1. fázisTaking peoplePersonalized DC Vaccine for Postoperative Cancer
- Where
- Chengdu
- Életkor
- 18 év to 100 év
- People
- 80
- Run by
- Sichuan University
See details and how to joinNCT04147078 - 1/2. fázisTaking peoplePhase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 51
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT05319639 - No phaseTaking peopleEffect of Premedication With Pronase on Mucosal Cleanliness During EGD
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 3000
- Run by
- Changhai Hospital
See details and how to joinNCT06713421 - 2. fázisTaking peopleFMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
- Where
- Changzhou
- Életkor
- 18 év to 80 év
- People
- 198
- Run by
- Changzhou No.2 People's Hospital
See details and how to joinNCT06405113 - No phaseTaking peopleNanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue
- Where
- Shenyang
- Életkor
- 18 év to 75 év
- People
- 76
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06830018 - No phaseTaking peopleChemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
- Where
- Anyang, Luoyang
- Életkor
- 18 év to 75 év
- People
- 196
- Run by
- The First Affiliated Hospital of Henan University of Science and Technology
See details and how to joinNCT02972372 - 2. fázisNot yet taking people in KínaNeoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer
- Where
- Hexi District
- Életkor
- 18 év to 75 év
- People
- 57
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06814158 - 2. fázisTaking peoplePD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
- Where
- Shenzhen
- Életkor
- 18 év to 79 év
- People
- 62
- Run by
- Wan He
See details and how to joinNCT05033392 - 1/2. fázisTaking peoplePostoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
- Where
- Hefei
- Életkor
- 18 év to 75 év
- People
- 70
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT05937438 - No phaseTaking peopleEffectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer
- Where
- Beijing
- Életkor
- 50 év to 69 év
- People
- 21 000
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06306755 - No phaseTaking peopleInvestigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients
- Where
- Suzhou
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Zhao Jun
See details and how to joinNCT06790797 - 2. fázisTaking peopleClinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT06791083 - 2. fázisTaking peopleLow-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06791148 - 2. fázisTaking peoplePD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 20
- Run by
- Peking University Third Hospital
See details and how to joinNCT06792162 - No phaseTaking peopleThe Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 600
- Run by
- Fudan University
See details and how to joinNCT06786169 - 1/2. fázisTaking peopleA Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
- Where
- Shenzhen
- Életkor
- 18 év and over
- People
- 52
- Run by
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
See details and how to joinNCT06776770